Mirati Therapeutics, Inc. Current Ratio 2013-2023 | MRTX
Mirati Therapeutics, Inc. current ratio from 2013 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2023-09-30 |
$1.04B |
$0.14B |
7.54 |
2023-06-30 |
$0.82B |
$0.14B |
5.85 |
2023-03-31 |
$0.94B |
$0.13B |
7.54 |
2022-12-31 |
$1.11B |
$0.16B |
6.96 |
2022-09-30 |
$1.23B |
$0.13B |
9.65 |
2022-06-30 |
$1.20B |
$0.12B |
10.10 |
2022-03-31 |
$1.34B |
$0.12B |
10.87 |
2021-12-31 |
$1.51B |
$0.14B |
10.50 |
2021-09-30 |
$1.17B |
$0.12B |
9.60 |
2021-06-30 |
$1.28B |
$0.18B |
7.07 |
2021-03-31 |
$1.30B |
$0.08B |
16.91 |
2020-12-31 |
$1.40B |
$0.07B |
19.64 |
2020-09-30 |
$0.60B |
$0.07B |
8.84 |
2020-06-30 |
$0.65B |
$0.06B |
11.34 |
2020-03-31 |
$0.71B |
$0.06B |
12.58 |
2019-12-31 |
$0.42B |
$0.05B |
8.68 |
2019-09-30 |
$0.47B |
$0.04B |
13.15 |
2019-06-30 |
$0.50B |
$0.03B |
17.57 |
2019-03-31 |
$0.31B |
$0.03B |
12.21 |
2018-12-31 |
$0.23B |
$0.03B |
8.67 |
2018-09-30 |
$0.25B |
$0.02B |
11.22 |
2018-06-30 |
$0.26B |
$0.02B |
14.54 |
2018-03-31 |
$0.15B |
$0.02B |
9.56 |
2017-12-31 |
$0.16B |
$0.01B |
11.42 |
2017-09-30 |
$0.08B |
$0.01B |
5.85 |
2017-06-30 |
$0.09B |
$0.01B |
7.86 |
2017-03-31 |
$0.11B |
$0.01B |
9.57 |
2016-12-31 |
$0.06B |
$0.02B |
3.97 |
2016-09-30 |
$0.08B |
$0.01B |
5.53 |
2016-06-30 |
$0.09B |
$0.01B |
6.75 |
2016-03-31 |
$0.11B |
$0.01B |
10.16 |
2015-12-31 |
$0.13B |
$0.01B |
12.80 |
2015-09-30 |
$0.14B |
$0.01B |
14.44 |
2015-06-30 |
$0.06B |
$0.01B |
8.58 |
2015-03-31 |
$0.07B |
$0.01B |
13.93 |
2014-12-31 |
$0.03B |
$0.01B |
6.05 |
2014-09-30 |
$0.04B |
$0.01B |
7.24 |
2014-06-30 |
$0.05B |
$0.05B |
1.10 |
2014-03-31 |
$0.06B |
$0.04B |
1.31 |
2013-12-31 |
$0.06B |
$0.04B |
1.66 |
2013-09-30 |
$0.02B |
$0.04B |
0.41 |
2013-06-30 |
$0.02B |
$0.02B |
1.34 |
2013-03-31 |
$0.03B |
$0.01B |
5.43 |
2012-12-31 |
$0.04B |
$0.01B |
7.37 |
2012-09-30 |
$0.00B |
|
0.00 |
2012-06-30 |
$0.00B |
|
0.00 |
2012-03-31 |
$0.00B |
|
0.00 |